We were thrilled to host a discussion today between two leading experts on CRISPR gene editing. Professor Debra Mathews of the Berman Institute for Bioethics at Johns Hopkins joined Professor Jake Sherkow of New York Law School for a rich discussion about the policy questions and legal landscape surrounding this potent new biotechnology.
Dr. Mathews’s academic work focuses on ethics and policy issues raised by emerging biotechnologies, with particular focus on genetics, stem cell science, neuroscience and synthetic biology. With other colleagues, Dr Matthews is the author of CRISPR: A path through the thicket, a paper in Nature that discusses the ethical questions of genome editing and present recommended actions for continued research.
Jake Sherkow is a Professor of Law at the Innovation Center for Law and Technology at New York Law School, where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation. Prof. Sherkow is the author of over 30 articles on these and related topics in both scientific journals and traditional law reviews, including Science, Nature, and the Yale Law Journal and the Stanford Law Review online.
Both speakers generously agreed to let us share their slides from the event.
Dr. Mathews’s presentation, Human Genome Editing, Ethics & Policy, is available here.
Prof. Sherkow’s presentation, CRISPR, Patents and the Public Health, is available here.